The pathogenesis of autism spectrum disorder (ASD) likely involves genetic and environmental factors, impacting the complex neurodevelopmental and behavioral abnormalities of the disorder. Scientific research studies emerging within the past two decades suggest that immune dysfunction and inflammation have pathogenic influences through different mechanisms, all leading to both a chronic state of low grade inflammation, and alterations in the central nervous system and immune response, respectively. The high mobility group box-1 protein (HMGB1) is an inflammatory marker which has been shown to play a role in inducing and influencing neuroinflammation. Current evidences suggest a possible role in the multiple pathogenic mechanisms of ASD. The aim of this manuscript is to review the major hypothesis for ASD pathogenesis, with specific regards to the immunological ones, and to provide a comprehensive review of the current data about the association between HMGB1 and ASD. A systematic search has been carried out through Medline via Pubmed to identify all original articles published in English, on the basis of the following keywords: "HMGB1", "autism", "autism spectrum disorder", "neuroinflammation", and "child".
suggest that there are more environmental components than previously believed (8) . Many environmental factors associated with the risk of ASD have been identified, and one candidate is the host inflammatory response (9) . The aim of this manuscript is to review the major hypotheses for ASD pathogenesis, with specific regards to the immunological ones, and to provide a comprehensive review of the current data about the association between HMGB1 and ASD. A systematic search was carried out through Medline via Pubmed (https:// www.ncbi .nlm.nih. gov/ pubmed) to identify all original articles published in English, on the basis of the following keywords:
"HMGB1", "autism", "autism spectrum disorder", "neuroinflammation", and "child".
Imunological dysfunction and inflammation in autism spectrum disorders
Both innate and adaptive branches of the immune system can impact neural development, cognitive functions, and behavioral pattern. From fetal development to adulthood, the immune system and central nervous system (CNS) interact with each other, influencing both systemic immune response (peripheral immune system) and local CNS immune function (the so-called 'neuroimmunity') (10) . During fetal development, the activation of the maternal immune system may lead to changes in neural development; this is an important risk factor for ASD. Various interrelated factors may cause dysregulation of the maternal immune system. A study conducted by Zerbo et al. (11) found that maternal infectious diseases diagnosed at a hospital admission, especially bacterial ones, were related to increased risk of ASD. Infections during pregnancy, such as rubella (12) (13) (14) or influenza virus (15) , can create an inflammatory immune environment and trigger the production of maternal cytokines and chemokines, which can not only affect directly the placenta but also may cross the placenta, and enter in the fetal compartment, exerting effects on the fetus development (10) . These effects can also be More larger-scale studies are needed to be performed to clarify the role of HMGB1 in the pathogenesis of autism spectrum disorder, potentially leading to novel disease markers and targeted therapeutics.
